ID

13745

Descrição

A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01055483

Link

https://clinicaltrials.gov/show/NCT01055483

Palavras-chave

  1. 02/03/2016 02/03/2016 -
Titular dos direitos

CC BY-NC 3.0

Transferido a

2 de março de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Acute Myeloid Leukemia NCT01055483

Eligibility Acute Myeloid Leukemia NCT01055483

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with cytopathologically confirmed diagnosis of aml according to who criteria, excluding acute promyelocytic leukemia.
Descrição

patients with cytopathologically confirmed diagnosis of aml according to who criteria, excluding acute promyelocytic leukemia.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0456521
UMLS CUI [2]
C0023487
first relapsed aml
Descrição

first relapsed aml

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0277556
UMLS CUI [1,3]
C0205435
primary refractory aml defined as failure to respond to initial induction chemotherapy (no cr) or recurrence within 6 months of initial cr.
Descrição

primary refractory aml defined as failure to respond to initial induction chemotherapy (no cr) or recurrence within 6 months of initial cr.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0205269
age more than 18 years
Descrição

age more than 18 years

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status < 2
Descrição

ecog performance status < 2

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with deacetylase inhibitor
Descrição

prior treatment with deacetylase inhibitor

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512474
UMLS CUI [1,2]
C1514463
concurrent therapy with any other investigational agent
Descrição

concurrent therapy with any other investigational agent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1875319
UMLS CUI [1,2]
C0009429
patients who have received cumulative doses (or its equivalent to other anthracyclines) of more than 360 mg/m2 of doxorubicin will be excluded from the study.
Descrição

patients who have received cumulative doses (or its equivalent to other anthracyclines) of more than 360 mg/m2 of doxorubicin will be excluded from the study.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2986497
clinical symptoms suggesting cns leukemia
Descrição

clinical symptoms suggesting cns leukemia

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1332884
UMLS CUI [1,2]
C1457887
lvef below 45% other protocol-defined inclusion/exclusion criteria may apply
Descrição

lvef below 45% other protocol-defined inclusion/exclusion criteria may apply

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0428772

Similar models

Eligibility Acute Myeloid Leukemia NCT01055483

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
AML cytopathologically confirmed, except APL
Item
patients with cytopathologically confirmed diagnosis of aml according to who criteria, excluding acute promyelocytic leukemia.
boolean
C0023467 (UMLS CUI [1,1])
C0456521 (UMLS CUI [1,2])
C0023487 (UMLS CUI [2])
first relapsed AML
Item
first relapsed aml
boolean
C0023467 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
refractory aml
Item
primary refractory aml defined as failure to respond to initial induction chemotherapy (no cr) or recurrence within 6 months of initial cr.
boolean
C0023467 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
age
Item
age more than 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG
Item
ecog performance status < 2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
deacetylase inhibitor
Item
prior treatment with deacetylase inhibitor
boolean
C1512474 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
investigational agent
Item
concurrent therapy with any other investigational agent
boolean
C1875319 (UMLS CUI [1,1])
C0009429 (UMLS CUI [1,2])
doxorubicin cumulative dose
Item
patients who have received cumulative doses (or its equivalent to other anthracyclines) of more than 360 mg/m2 of doxorubicin will be excluded from the study.
boolean
C0013089 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
cns leukemia
Item
clinical symptoms suggesting cns leukemia
boolean
C1332884 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
LVEF
Item
lvef below 45% other protocol-defined inclusion/exclusion criteria may apply
boolean
C0428772 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial